WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced today that it will attend the 2009 UBS Global Healthcare Services Conference being held February 9 through 11, 2009 at the Waldorf Astoria in New York City. Ron Zwanziger, Chief Executive Officer, will attend, as will Jon Russell, Vice President of Finance, and Ron Geraty, CEO of Alere. The Company's presentation is scheduled for Tuesday, February 10, 2009 at 2:00 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the UBS Investment Bank website at http://cc.talkpoint.com/ubsx001/020909a_cy/?entity=26_05LIP5D. A replay of the webcast will be available via the links above for approximately ninety days from the date of the webcast. During his presentation, Mr. Zwanziger may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
|SOURCE Inverness Medical Innovations, Inc.|
Copyright©2009 PR Newswire.
All rights reserved